Walter P. Hölzle has been the owner of Hölzle, Buri & Partner Consulting since October 2000. In the period from 1989 to 2000, Mr Hölzle was General Manager of Warner-Lambert (Switzerland) AG in Baar. He was responsible for the business in Switzerland, Austria and Central Europe. He is the president of VIPS (Vereinigung Pharmafirmen in der Schweiz www.vips.ch), the Swiss Society of Pharmaceutical Industry, and LAWG Vice-Chairman of PhRMA Switzerland (Pharmaceutical Research and Manufacturer of America).After the successful completion of his studies at the Swiss Institute for Druggists (ESD), Walter Hölzle completed further education with a certified diploma in sales and marketing management in Zürich und also for General Management MCR at IMD (International Institute for Management Development) in Lausanne. He worked for a number of years at Sandoz in Basel and from 1981 to 1989 was the General Manager/Area Manager Central & Eastern Europe with Alcon Pharmaceuticals in Cham.

Carmen Balmer is the administration manager of HBPC and is responsible for coordinating all mandates.

Adrien is a Senior Recruitment Consultant working for CK QLS, with the primary focus of working with candidates searching for roles within Switzerland.

He specialises in working with candidates searching for roles within Switzerland.

Ben is the Managing Director for CK Group. He is responsible for managing teams across Life Science and Clinical recruitment, as well as business development and growth across multiple platforms.

Robert is Recruitment Consultant working for CK QLS, with the primary focus of working with candidates searching for roles within Switzerland.

As administrative officer Jenny Erdin is responsible for special Projects

Caroline Hölzle joined the team in 2011 and provides support in recruitment, assessment and team development specialized in the field of Sales&Marketing.

Petra Erni has an expertise which is based on more than 10 years of experience in medical and commercial functions in the pharmaceutical industry as well as from her work as a pharmacist / assessor in the drug section at the Federal Office of Public Health (FOPH). She offers a solid and in depth knowhow in market access issues and can support companies with their pricing and reimbursement strategy.

Dr.med. Patrick Schneider combines medical knowledge with his 11 years experience as strategic consultant at the Boston Consulting Group (BCG) and IMS Health. At HBPC he supports strategy projects as well as operational excellence with focus on Pharma and Health Care.

Richard Bergström offers a success record from the global governmental affairs management, political communication and lobby work in the global and specific European health care market. As expert he can help you to shape and achieve your corporate political and market access targets. In addition he is an expert in safety issues including track and trace. He joined our team form EFPIA where he served as director general.

Nicolas Florin has been working for many years on the digitization of supply chain processes. As part of his long-term position as Managing Director of the not-for-profit organization GS1 Switzerland, he has worked in national and international committees, among others, on the topics UDI (Unique Device Identification) or FMD (Falsified Medicines Directive). As a part-time Managing Director of the refdata foundation, he promotes the clear referencing of products and partners in the healthcare sector, thus promoting efficient cooperation between all stakeholders, including the authorities. Previously, he worked for the Galenica Group for more than 10 years, first as Head of Controlling for Wholesaler Galexis and at last, as Managing Director for the Europe-wide Alloga Group. He has a worldwide network of contacts and speaks in addition to Romansch, another five languages

Dr. Johannes Fröhlich betreut bei Hölzle, Buri & Partner Consulting Projekte als Qualified Person und Swissmedic Spezialist und wird Sie neben Dr. Peter Alig bei Regulatory Affairs Fragen, inklusive Audits unterstützen.